SANDY, Utah, Aug. 18, 2016 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, was joined by senior public officials today to celebrate the 60th anniversary of its manufacturing facility in Sandy, Utah. BD also announced that it recently approved a $20 million investment in the BD Sandy site as part of its broader plan to invest in manufacturing capacity and support anticipated growth in the catheter solutions platform.
The site traces its roots to Deseret Pharmaceutical, which started in Murray, Utah in 1956. BD acquired the facility in Sandy in 1986, which has grown to 550,000 sq. ft. and employs more than 1,200 associates.
BD products manufactured in Sandy include intravenous (IV) catheters and valves, blood collection devices and surgical products. The site is responsible for more than 200 global patents related to IV catheters. Products manufactured in Sandy are sold in 96 countries worldwide. Associates at the BD facility in Sandy have an average tenure of 13 years.
Tom Polen, president of the BD Medical segment, and Bill Tozzi, worldwide president of Medication and Procedural Solutions for BD, welcomed associates, elected leaders and other guests to the celebration.
"Our Sandy facility is one of the largest and longest running manufacturing sites across all of BD," Polen said. "We would like to thank our associates here for their continued hard work and dedication to advancing the world of health in Utah and across the globe."
Joining the BD leaders and providing remarks at the celebration were:
- U.S. Senator Orrin Hatch
- U.S. Representative Mia Love
- Office of U.S. Senator Mike Lee
- State Senate President Wayne Niederhauser
- State Representative Steve Eliason
- Sandy City Mayor Tom Dolan
- Theresa Foxley, Utah Governor's Office of Economic Development
"I wish to congratulate BD on its 60th anniversary of success at its manufacturing facility in Utah," said U.S. Senator Orrin Hatch. "I have had the pleasure of touring this facility many times, and my interactions with the associates here have helped me see why BD is a global leader in the products they manufacture and the technologies they continue to develop. BD has been a valuable contributor to Utah's business climate. I am confident that the company will continue to enjoy many years of success in the Beehive State."
U.S. Representative Mia Love said, "I'm thrilled to celebrate BD's 60th anniversary in Sandy. The company is a shining example of what makes Utah great. BD's commitment to cutting-edge advancements in medical technology, to environmental stewardship, to providing great jobs in our state, and its commitment to giving back to the community make all of us proud. We are very fortunate to have a high-quality corporation like BD in Utah's 4th District."
U.S. Senator Mike Lee said, "BD's Sandy facility has been a critical component of both the company and the surrounding community for generations. After 60 years and with more than 1,200 associates currently based here in Utah, BD has helped build families and communities close to home while helping heal and treat countless patients across the world."
BD's operations in Sandy have received Utah's top award for Excellence in Energy Efficiency in Industry and has been recognized by the U.S. Environmental Protection Agency for achieving the Energy Star Challenge for Industry for energy reduction. The facility has operated since 2008 using 100 percent of its power demands from renewable energy sources ― becoming the first BD site to do so. In 2012, the facility became a landfill-free site, where waste is reduced, recycled or converted into energy.
BD in Sandy is more than a successful manufacturing site, and has a long history of giving back to the community. Since 2010, BD in Sandy has contributed more than $500,000 to the local community and volunteer outreach to organizations such as People Helping People, Juvenile Diabetes Research Foundation, American Heart Association, Meals on Wheels and the Utah Food Bank.
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, optimize respiratory care and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has more than 45,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health. For more information on BD, please visit bd.com.
SOURCE BD (Becton, Dickinson and Company)